ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

RNXT RenovoRx Inc

1.39
-0.061 (-4.20%)
시간외 거래
최종 업데이트: 05:02:01
15분 지연
기업명 주식 심볼 시장 주식 타입
RenovoRx Inc RNXT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.061 -4.20% 1.39 05:02:01
개장가 저가 고가 종가 전일 종가
1.48 1.38 1.48 1.39 1.451
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
14/05/202422:00BWRenovoRx to Participate in Fireside Chat at the A.G.P...
13/05/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
11/05/202406:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/05/202405:50EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/05/202405:47EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/05/202422:00BWRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital..
18/04/202421:30BWRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity..
16/04/202421:30BWRenovoRx Highlights Recent Presentation of Clinical Data..
15/04/202421:00BWRenovoRx Closes $11.1 Million Private Placement, Providing..
08/04/202421:30BWRenovoRx Announces $11.1 Million at Market Private Placement
05/04/202421:30BWRenovoRx to Present at the Canaccord Genuity Horizons in..
12/03/202422:00BWRenovoRx to Present at the 36th Annual ROTH Conference on..
09/03/202406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:05BWRenovoRx Highlights Key Leadership Promotions
13/02/202409:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:30EDGAR2Form 8-K - Current report
06/02/202422:30BWRenovoRx CEO Issues Letter to Shareholders
31/01/202409:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202408:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/01/202423:06EDGAR2Form 8-K - Current report
29/01/202422:30BWRenovoRx Closes $6.1 Million Private Placement
24/01/202411:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202411:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202411:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/01/202422:30EDGAR2Form 8-K - Current report
21/12/202322:30BWRenovoRx Engages Oklahoma University (OU) Health as First..
19/12/202322:30BWRenovoRx Announces Clinical Data Abstract at the 2024..
19/12/202306:15EDGAR2Form 8-K - Current report
13/12/202322:31BWRenovoRx Files New International Patent for Novel Targeted..
28/11/202303:23EDGAR2Form DEF 14A - Other definitive proxy statements
18/11/202307:30EDGAR2Form PRE 14A - Other preliminary proxy statements
16/11/202322:35BWRenovoRx Expands Scientific Advisory Board with Appointment..
14/11/202322:30BWRenovoRx Reports Third Quarter 2023 Financial Results and..
14/11/202306:58EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:15EDGAR2Form 8-K - Current report
05/10/202305:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202321:30BWRenovoRx to Present at the ROTH MKM Healthcare Opportunities..
26/08/202305:15EDGAR2Form 8-K - Current report
17/08/202321:30EDGAR2Form 8-K - Current report
17/08/202321:30BWRenovoRx Reports Second Quarter 2023 Financial Results and..
17/08/202303:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/08/202304:57EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
31/07/202321:30BWRenovoRx to Present at the 43rd Annual Canaccord Genuity..
20/07/202321:00BWRenovoRx and Imugene Announce Collaboration to Deliver..
29/06/202322:27EDGAR2Form 8-K - Current report